Morningstar, Inc. (MORN) Stock Price & How to Invest

Morningstar is an investment-research and financial-data provider whose products span five reportable segments: the Morningstar Direct Platform (data, research, Direct, and Advisor Workstation), PitchBook (private-capital data, analytics, and AI-enabled software for venture capital, private equity, private credit, and M&A), Morningstar Credit (credit ratings, research, and analytics through DBRS Morningstar), Morningstar Wealth (investment products, advisor platforms, and managed portfolios), and Morningstar Retirement. The business is built on proprietary datasets, independent research, and widely used ratings and indexes that embed deeply into advisor, asset-manager, and institutional workflows, giving it high switching costs and durable, largely recurring revenue.

The investment picture centers on a shift in growth mix away from the mature core fund-research business toward faster-growing franchises. PitchBook continues to expand private-market data and AI features, Morningstar Credit has rebounded strongly with structured-finance and corporate ratings activity, and management has focused on margin discipline after a heavy investment period, which drove sharp operating-leverage gains in recent quarters. The tradeoff is that revenue growth is roughly low-double-digit rather than explosive, parts of the business are cyclical (ratings volumes track debt issuance, and license revenue tracks markets), and the stock reprices with both software and financial-data sentiment. At a mid-teens to high-teens earnings multiple, the shares price in steady growth plus continued margin recovery rather than a dramatic re-acceleration.

Credit-ratings revenue is cyclical and tracks debt-issuance volumes, so a slowdown in structured finance or corporate issuance can quickly pressure a fast-growing segment. Core fund-research and license revenue is more mature and exposed to market levels and fee compression among asset-manager clients. Morningstar competes against far larger, better-capitalized data and index rivals (Bloomberg, S&P Global, MSCI, FactSet, LSEG, Moody's) that can bundle products and pressure pricing. AI and new fintech entrants could commoditize parts of the data and research business over time. The stock trades at a premium multiple, so any stall in PitchBook growth, credit volumes, or margin recovery can compress the valuation.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Morningstar, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$2.5B
• Q1 2026 revenue: ~$644.8M (up ~10.8% YoY)
• Q1 2026 diluted EPS: ~$2.73 (up ~50% YoY)
• Morningstar Credit growth: ~+38% YoY (Q1 2026)
• Market cap: ~$7B
• P/E (TTM): ~18x

Morningstar reported Q1 2026 revenue near $644.8 million, up about 11% year over year, with operating profit up more than 35% and diluted EPS around $2.73, up roughly 50%, both ahead of consensus. Growth was broad-based but led by Morningstar Credit (up about 38%) and PitchBook, and the company continued buying back stock. At a mid-to-high-teens trailing earnings multiple, the shares reflect steady growth plus continued margin recovery rather than a sharp re-acceleration.

There are three common ways to get MORN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so MORN sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where MORN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

MORN is a founder-influenced, data-moat business whose story turns on PitchBook, credit ratings, and margin expansion continuing to outrun the maturing core research franchise.

Whether MORN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MORN a buy?, and where the stock could go from here in the MORN stock forecast.

For income investors, whether MORN pays a dividend and how the payout looks is covered in does MORN pay a dividend?